Lumen Technologies, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Lumen Technologies, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.40B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $13.11B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $14.56B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $17.48B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $19.69B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $20.71B | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | $5.57B | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $5.61B | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $5.58B | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $5.65B | Feb 28, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.33B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $12.13B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $13.52B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $16.11B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $17.80B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $18.80B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $19.51B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $21.04B | Feb 25, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.74B) | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | ($55.00M) | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | ($10.30B) | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | ($1.55B) | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $2.03B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | ($1.23B) | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | $223.00M | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $302.00M | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $371.00M | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | ($6.17B) | Feb 28, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($812.00M) | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $460.00M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | ($9.58B) | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $95.00M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $4.29B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $962.00M | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | $847.00M | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $950.00M | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $976.00M | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | ($5.50B) | Feb 28, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.20B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $2.97B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $3.20B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $3.08B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $2.90B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $3.46B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $3.72B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $4.17B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $3.51B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $3.45B | Mar 11, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.74B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $4.33B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $2.16B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $4.74B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $6.50B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $6.52B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $6.68B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $7.03B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $3.88B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $4.61B | Mar 11, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $3.05B | Feb 27, 2014 |
| FY2012 | Dec 31, 2012 | $2.92B | Mar 1, 2013 |
| FY2011 | Dec 31, 2011 | $2.41B | Feb 28, 2012 |
| FY2010 | Dec 31, 2010 | $863.77M | Mar 30, 2011 |
| FY2010 | Dec 31, 2009 | $754.54M | Mar 30, 2011 |
| FY2010 | Dec 31, 2008 | $286.82M | Mar 30, 2011 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $34.34B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $33.50B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $34.02B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $45.61B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $57.99B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $59.39B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $64.74B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $70.26B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $75.61B | Mar 11, 2019 |
| FY2017 | Dec 31, 2016 | $47.02B | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.12B) | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $464.00M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $417.00M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $10.37B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $11.78B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $11.16B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $13.47B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $19.83B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $23.49B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $13.40B | Mar 11, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.96B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $1.96B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $12.66B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $15.99B | Feb 22, 2024 |
| FY2022 | Jan 31, 2021 | $0 | Feb 23, 2023 |
| FY2022 | Dec 31, 2020 | $18.87B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $21.53B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $28.03B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $30.48B | Feb 28, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($19.70B) | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | ($17.96B) | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | ($17.91B) | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | ($7.61B) | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | ($6.00B) | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | ($8.03B) | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | ($6.81B) | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | ($1.64B) | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $1.10B | Mar 11, 2019 |
| FY2017 | Dec 31, 2016 | ($1.00M) | Mar 1, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.00B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.89B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $2.23B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $1.25B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $354.00M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $406.00M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.69B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $488.00M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $551.00M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $222.00M | Mar 11, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2010 | Dec 31, 2010 | $7.33B | Mar 30, 2011 |
| FY2010 | Dec 31, 2009 | $7.75B | Mar 30, 2011 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | (10) | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | (5) | Feb 28, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | (10) | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | (1) | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | (5) | Feb 28, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.03B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 1.01B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | 1.01B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | 1.00B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | 1.02B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | 1.10B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | 1.09B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | 1.08B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | 1.07B | Mar 11, 2019 |
| FY2017 | Dec 31, 2016 | 546.55M | Mar 1, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 21, 2012 | $454.00M | Mar 1, 2013 |
| FY2012 | Sep 21, 2012 | $452.00M | Mar 1, 2013 |
| FY2012 | Jun 15, 2012 | $453.00M | Mar 1, 2013 |
| FY2012 | Mar 16, 2012 | $452.00M | Mar 1, 2013 |
| FY2011 | Dec 31, 2011 | $449.00M | Feb 28, 2012 |
| FY2012 | Dec 16, 2011 | $449.00M | Mar 1, 2013 |
| FY2011 | Sep 30, 2011 | $449.00M | Feb 28, 2012 |
| FY2012 | Sep 16, 2011 | $449.00M | Mar 1, 2013 |
| FY2011 | Jun 30, 2011 | $436.00M | Feb 28, 2012 |
| FY2012 | Jun 16, 2011 | $436.00M | Mar 1, 2013 |